Digital Health Technologies In Clinical Research: Transforming The Future Of Clinical Trials

Clinical studies are an essential part of clinical research and are crucial for determining the safety, effectiveness, and clinical performance of medical treatments and healthcare procedures. Traditionally, clinical trials have conducted through centralized research centers where informed consent, recruitment, follow-up, clinical assessment and data collection are done by the patients who come to the facilities at specific times. However, frequent visits to the site can create issues of time, travel, geography, and participation, and could limit access to clinical research for individuals who live far from the research site.[1]

Decentralized clinical trial (DCTs) is a more patient-focused and flexible approach that has transformed from being predominantly held at conventional clinical trial sites. Depending on the design of the study, DCTs can involve telemedicine, remote visits, home-based health care, direct-to-participant services, digital data collection, and remote monitoring. These techniques can help increase participation, reduce participant burden, and help research in real world contexts.

Digital Health Technologies (DHTs) have also seen a significant evolution and the potential for decentralized clinical research has grown. Communication, data collection, assessment of outcomes, and monitoring can be facilitated by remote monitoring technologies, telemedicine, electronic informed consent, electronic patient-reported outcomes, electronic health records, wearables, and mobile health applications, outside of the typical research environments. In addition, they are able to encourage more frequent evaluation of health outcomes and health information from patients.[3]

A comprehensive scoping review identified 510 research articles covering 169 medical conditions, with many of these studies utilising digital technologies to collect patient generated behavioural, physiological and symptom related data. Wearable technologies, and mobile applications, were important approaches for measuring real-world clinical outcomes.[4] These tools made people realize the potential of using Digital Health Technologies (DHTs) for data collection in real-world setting for clinical research.  

4–Role of Digital Health Technologies in Different Clinical Trial Models

4.1 Traditional Clinical Trials

Through established research sites, where the majority of standard clinical trials are carried out,Participants attend scheduled appointments for informed consent, clinical assessments, and recruitment.data collection, intervention-related procedures, and follow-up. Most trial operations includebetween research employees and participants.Without being modified, conventional trials can include digital health technologies.overall site-based structure. Electronic data collection, ePROs, and wearable technologies are examples of such technologies.Remote monitoring, digital outcome evaluation, and equipment may all enhance traditional processes and increase the management and collection of trial data.

DHTs play essential roles in conventional tests:

● Management and collection of electronic data

● Evaluation of Digital Outcomes

● Monitoring remotely between appointments

● Gathering patient-generated data via wearables and ePROs

Participant travel, planned site visits, and physical exams may still be required in traditional trials.infrastructure for research. Consequently, DHT integration may be able to lessen some site-based demands But it doesn't decentralize the trial.

4.2 Hybrid Clinical Trials

Remote or decentralized activities are combined with conventional site-based activities in hybrid clinical trials. Some experiment processes may be completed remotely, while others require in-person participation. Hybrid trials' remote components may be supported by Digital Health Technologies (DHTs), including eConsent, wearables, telemedicine, ePROs, and remote monitoring.

Hybrid clinical trials are characterized by:

• Blended In-Person and Online Events
• Adaptable selection of processes suitable for remote execution
• Remote data collection and participation with DHTs
• Retention of required site-based clinical operations.[1,5,16]

4.3 Decentralized Clinical Trials (DCTs)

DCTs (Decentralized Clinical Trials) are trials that involve specific operations performed conducted outside of traditional research sites using appropriate technology, services, and distant strategies. The purpose of DCTs is to get clinical research activities closer to participants.places and customary environments, lessening reliance on regular physical site visits.By supporting remote recruitment, eConsent, and real-time monitoring of participants, DHTs are essential to DCTs.remote monitoring, telemedicine, digital, ePROs, and wearable data collection evaluation of results.

The primary functions of DHTs within DCTs include:

● Telemedicine: assists with follow-ups and remote consultations.

● Wearables and sensors – deliver continuous or repeated physiological and behavioral information.

● ePROs and mobile apps make it easier to gather information provided by participants. activities pertaining to communication and study.

● EHRs and Digital Data Sources – support participant identification, data collection, and generation of evidence.

● Remote monitoring - makes it possible to gather and follow up on study-related data. sites outside of research.

Participant access may be enhanced by DCTs, which can lessen geographic and travel restrictions.convenience and accessibility. Additionally, they enable data collection from participants in the investigation.rather than just at scheduled site visits, they are in their actual settings.To successfully implement digital accessibility, we must think carefully about how it relates to the internet.data quality, privacy, cybersecurity, and interoperability, as well as the accessibility of devices and digital literacy.regulatory compliance.Not every trial task can be completed remotely. Physical may be necessary for some procedures.direct contact with healthcare professionals, specialized equipment, or an examination.Thus, the study design should dictate the level of decentralization, participant population, clinical requirements, outcome measures, and intervention.[1,11,16]

5 – Benefits of Digital Health Technologies 

5.1 Patient-Centric Approach, Convenience and Reduced Participant Burden

By allowing a few clinical research operations to be carried out closer to participants and, if necessary, in their natural surroundings, digital health technologies can promote a patient-centered strategy.

The key benefits are:

• Fewer in-person visits: Telemedicine, mobile apps, wearable electronics, ePROs, and remote monitoring can all cut down on the frequency of site visits.
• Reduced travel stress - Remote participation might reduce travel requirements, especially for participants who live far away from research sites.
• DHTs may acquire data during regular activities, promoting participant-centered outcome assessment and data collection.
• Increased adaptability - Participants can communicate with research teams and finish study-related activities in flexible ways thanks to digital methods.

Accessibility, usability, digital literacy, and the availability of suitable technology must be taken into account when implementing digital strategies in a patient-centric manner to avoid the creation of new obstacles.

5.2 Better Participant Recruitment, Access and Retention

Digital health technologies can help researchers recruit participants by allowing them to connect with potential candidates through online platforms and remote communication. These digital methods can reach people beyond the usual research sites and make it easier for those who live far away to join studies. By using remote trial activities, participants can avoid traveling to sites, making it simpler and more convenient for them to take part in the research.

Tools like mobile apps, telemedicine, electronic consent forms (eConsent), electronic patient-reported outcomes (ePROs), and remote monitoring keep the lines of communication open between participants and research teams throughout the study.

The main advantages include:

•  A broader recruitment range
•  Better access for participants located in different areas
• Less need for travel and site visits
•  Ongoing digital interaction during the study

However, participation may still be limited by issues like lack of digital access, problems with usability, low digital skills, and other technology-related challenges.[11,19]

5.3 Remote and Continuous Data Collection

Digital health technologies enable researchers to collect clinical and patient-generated data remotely, meaning participants don’t need to visit the research site for every assessment. Tools like wearable devices, sensors, mobile apps, electronic patient-reported outcomes (ePROs), and remote monitoring systems can collect information while participants go about their daily activities. These technologies help in collecting data repeatedly and continuously, giving insights at various times rather than just during scheduled visits. The data collected can include information about health measurements, behaviors, symptoms, and activities based on what the study needs and the technology used.

By gathering data remotely, researchers get information from participants in their everyday environments, which enhances traditional clinical assessments. Combining different digital data sources also helps in providing a more comprehensive and ongoing evaluation during clinical research.[4]

5.4 Improved Data Quality and Data Availability

Digital health technologies make it easier to collect clinical and patient-generated data in a structured and timely way. Electronic platforms help reduce the need for paper-based methods, allowing for quicker access to study information for review and analysis.

 The main advantages include:

• Detailed and repeated measurements through wearables, sensors, mobile apps, and electronic patient-reported outcomes (ePROs).
•  Gathering of information related to physical health, behavior, symptoms, and results.
• Combining various digital data sources to create larger datasets for clinical research.
•  Enhanced availability of data for review, analysis, and creating evidence.

However, just having better access to data doesn't mean the quality will improve automatically. To ensure reliable digital research data, it's important to focus on validation, standardization, interoperability, participant engagement, and good data management.

5.5 Reduced Cost and Time

Digital health tools can lessen the number of in-person visits, which can help save time and travel for participants. Activities like telemedicine, electronic consent, remote monitoring, and online data collection let certain trial tasks be done without needing to visit a site in person. Collecting data digitally offers quick access to study details, which can help avoid delays that come from handling data by hand. Remote involvement might also cut down the time needed for both participants and research staff to finish specific trial tasks. Using technology can make trial processes more efficient, especially when different activities are combined through digital platforms.

5.6 Greater Flexibility and Efficiency in Clinical Trial Conduct

Digital health technologies offer more flexibility in how certain clinical trial tasks are carried out. By using remote and digital methods, researchers can mix on-site and off-site activities based on what the study needs.

DHTs can support various types of trials, such as traditional, hybrid, and decentralized ones. Tools like telemedicine, eConsent, electronic patient-reported outcomes (ePROs), wearables, and remote monitoring help link different activities within a digital process.

The main advantages include:

•  A flexible mix of remote and on-site tasks
• Better organization of data collection and monitoring
•  Enhanced communication between participants and the research team
•  Ability to adapt to the study design, participant demographics, treatment methods, and clinical needs

6–Challenges and Limitations of Digital Health Technologies

6.1 Data Privacy and Cybersecurity

Digital health technologies involve gathering, sharing, and storing health data from clinical settings, personal sources, and patients themselves. Tools like mobile apps, wearable gadgets, remote monitoring systems, and cloud platforms expand the number of digital methods used to manage research data. Because of this, protecting data privacy and confidentiality is crucial in digital clinical studies. It’s essential to take steps to keep data safe from unauthorized access, leaks, loss, or misuse.

Key factors to consider include:

• Safe methods for sending data
• Limited access to research information
•  Proper practices for managing data
•  Safeguarding data that is collected continuously and sent remotely

Researchers and tech providers need to think about privacy and cybersecurity needs while designing and implementing digital clinical research systems.[19]

6.2 Data Quality and Validation

Digital health technologies can create a large amount of clinical, physiological, behavioral, and patient-generated data from various sources. The data collected from wearables, sensors, mobile apps, and ePRO systems can differ in format, measurement features, and quality. To ensure their reliability and suitability for clinical research, digital devices and measures need proper technical and clinical validation. Without standardization, it becomes challenging to compare or combine data from different technologies. Factors related to participants, such as how they use the device, their commitment to using it regularly, and mistakes in entering data can also impact the quality and completeness of the data collected.

Key factors include:

•  Controlling the quality of data
•  Standardizing digital measures
•  Validating both technically and clinically
•  Ensuring participant adherence and accurate data entry

 Implementing suitable data management practices Before using digital endpoints and measures derived from digital health technology for assessing clinical outcomes or generating evidence, they must be validated properly.[4]

6.3 Interoperability and Data Integration

Digital health technologies collect data from various devices, apps, and online platforms. The differences in how this data is formatted and stored can make it hard to share and combine information across these technologies.To merge data from electronic health records (EHRs), wearables, mobile apps, electronic patient-reported outcomes (ePROs), and remote monitoring systems, we need compatible systems and proper data standards. When systems don't function well together, it can result in disorganized data, duplicated information, and difficulties in handling and understanding the data.

 Important factors to consider are:

• Systems and data formats that work well together Standardized structures for data
• Suitable technical setups
• Smooth processes for exchanging and integrating data

Effective integration of data is essential when combining information from different digital health technologies for clinical evaluations and creating evidence. Therefore, it's important to think about interoperability when choosing, setting up, and integrating these technologies in clinical research.

6.4 Digital Divide and Accessibility

The use of digital health technologies might be restricted due to differences in access to devices, internet service, and technology infrastructure. Participants may also vary in their ability to use digital tools, including their digital skills and knowledge.

These variations can create challenges for participation, especially for groups that have little access to digital technologies. Complicated designs and low usability can make it even harder for people to use these tools effectively.

Key issues include:

•  Limited access to devices and internet
• Variations in digital skills and knowledge
• Difficult-to-use interfaces or designs
• Lack of technical support

As a result, when conducting digital clinical research, it's important to think about accessibility, ease of use, digital skills, and the availability of technical help when choosing and implementing technology. Technologies that are easy to use and proper support for participants can help lower these barriers and avoid unintentionally leaving out certain groups of people.

6.5 Technical and Infrastructure Challenges

To use digital health technologies effectively, you need dependable devices, good internet access, software platforms, and the right technical setup. Issues like device breakdowns, loss of connectivity, software glitches, or problems with data transfer can disrupt trial activities.

Different digital health tools may need different amounts of technical help, upkeep, and training for participants. Combining various digital technologies can make managing the trial's infrastructure and data more complicated.

Key factors include:

• Dependability of devices and software
•  Internet access and data transfer
•  Technical help and maintenance
•  Training for participants and research staff
•  Backup plans for technical problems

6.6 Regulatory and Ethical Challenges

Digital health technologies (DHTs) used in clinical research must follow important regulatory and ethical rules. Their use can lead to worries about participant privacy, informed consent, data safety, and the proper handling of digital health information.

Before using digital technologies and measures from DHTs for clinical research outcomes, they may need to be validated and backed up with evidence. The rules that apply can change depending on the technology, what it's meant to do, the type of data gathered, and how it relates to the research.

Key factors include:

•  Protecting participant privacy and data
•  Ensuring informed and voluntary participation
• Validating digital technologies and their measures
• Following relevant regulations
• Using digital health data responsibly

The quick growth of digital technologies can make it hard to set clear standards for their assessment and use.It's essential to remember regulatory and ethical rules when designing, carrying out, and assessing clinical research that involves digital health technologies (DHTs).

6.7 Participant Adherence and Usability

The successful use of digital health technologies relies on participants being able to use them correctly and regularly throughout the study. If the interfaces are hard to navigate, there are technical issues, or the instructions are unclear, it may lead to problems with following through and continuing to use the technology.

In studies that involve digital health tools, how well participants stick to using these tools can affect how complete and trustworthy the data collected is. Using mobile apps, wearables, sensors, or electronic reporting systems regularly might also add extra requirements for participation.

Key factors include:

•  Easy-to-use design
•  Clear instructions and sufficient training
• Technical help
•  Regular use by participants
•  Tracking adherence and engagement

By providing proper training, technical support, and a user-friendly design, we can make it easier for participants to use these tools and keep them engaged. Therefore, when choosing and implementing digital health technologies in clinical research, it's important to focus on participant engagement and adherence.[11,19,4]

7 – Regulatory and Ethical Considerations

7.1 FDA Perspective

The U.S. Food and Drug Administration (FDA) plays a key role in assessing and regulating technologies and digital tools used in clinical research. Digital health technologies (DHTs) in clinical trials can include wearables, sensors, mobile apps, electronic patient-reported outcomes (ePROs), remote monitoring systems, and digital endpoints.

Before DHT-derived measures can support clinical research results, they need proper validation and evidence. The rules for their regulation and the proof needed may differ based on how they are intended to be used.

Regulatory issues are also crucial for decentralized clinical trials, especially for technologies that involve remote monitoring, eConsent, ePROs, and wearable devices. Having standardized and consistent regulatory approaches is important for the broader use of DHTs in clinical research.[5]

7.2 ICH Perspective

The International Council for Harmonisation (ICH) provides guidelines that are accepted around the globe to help make sure that clinical research is high-quality, safe, and reliable.As digital health technologies (DHTs) become more common, it's essential to have uniform methods for gathering, handling, and assessing digital data in clinical research environments. Data collected from wearables, sensors, mobile apps, and electronic systems must be managed and evaluated properly based on how it will be used. Key points include:

• Data integrity and validation
• Standardization and harmonization
• Participant protection
•  Proper documentation of digital processes 

Using uniform methods can help lessen the variations in how data generated by digital health technologies (DHT) are gathered, assessed, and included in clinical research. This supports their broader and consistent use.

7.3 CDSCO/Indian Regulatory Perspective

The Central Drugs Standard Control Organization (CDSCO) is the main authority in India that oversees the regulation of drugs and activities related to clinical research. As digital health technologies become more popular in clinical research, there is an increasing need for proper rules and consistent methods.Digital tools used in clinical trials can include electronic data collection, remote monitoring, eConsent, digital endpoints, and data generated by patients. Key factors to consider are data integrity, participant safety, privacy, informed consent, and the validation of these digital tools.

For decentralized and technology-driven clinical research, it is crucial to have clear regulatory guidelines to ensure that remote trial activities meet scientific, ethical, and quality standards. Aligning regulatory requirements can help with the responsible use of digital health technologies while keeping the reliability and integrity of clinical research data intact.

7.4 Ethical Considerations

Using digital health technologies in clinical research means we must protect the rights, privacy, confidentiality, and independence of participants. Participants need to understand exactly how their digital health data will be collected, kept, handled, and used.Electronic informed consent (eConsent) should help participants fully understand the study and willingly agree to take part. Ongoing or remote data collection might create extra concerns about privacy, data security, and how much control participants have over their information.

When implementing these technologies ethically, we also need to think about accessibility and the digital divide. This way, we ensure that people are not unfairly left out due to limited access to technology. Researchers must guarantee proper data protection, secure management of information, and responsible use of digital tools during the study.

Ethical issues are especially crucial when digital health technologies gather sensitive health information from patients remotely.[19,20]

8 – Future Perspectives and Emerging Trends

8.1 Artificial Intelligence and Machine Learning

Artificial Intelligence (AI) and Machine Learning (ML) are new technologies that can assist in various parts of clinical research. They can analyze large and complicated datasets produced by digital health tools.

AI/ML can aid in finding participants, examining data from patients, identifying digital biomarkers, and defining digital endpoints. Connecting with digital platforms can enhance how we interpret data and make decisions.

For future use, it’s important to focus on the quality of data, making sure it is validated, being transparent, ensuring privacy, and following regulations.

8.2 Advanced Wearables and Digital Biomarkers

Modern wearable devices and sensors can help gather data about people's physical health, behaviors, and activities continuously and from a distance while they go about their daily routines. This information can be useful in creating and evaluating digital biomarkers and endpoints, which give insights into changes in health, symptoms, activity levels, and how well treatments are working. To move forward, it will be important to validate these tools, standardize them, assess the quality of the data they collect, and gain approval from regulatory bodies. Combining wearables with other digital health technologies may enhance remote clinical research that focuses on patients. [12]

8.3 Growing Adoption of Hybrid and Decentralized Clinical Trials

Digital health technologies are set to enhance the ongoing use of hybrid and decentralized clinical trials (DCTs). Tools like telemedicine, electronic consent (eConsent), wearable devices, mobile apps, electronic patient-reported outcomes (ePROs), and remote monitoring allow certain trial tasks to be done from a distance.

Hybrid trials mix remote activities with important in-person steps, while DCTs aim to make suitable research tasks more accessible to participants and lessen travel challenges. Future trial designs will likely merge digital methods with traditional ones based on the needs of the study. For broader use, it's essential to focus on data quality, participant safety, accessibility, technical support, and meeting regulatory standards

8.4 Combining Digital Health Technologies with Real-World Evidence

Digital health technologies can produce real-world data (RWD) through devices like wearables, mobile apps, remote monitoring systems, electronic health records (EHRs), and other connected platforms. By merging data generated from these technologies with RWD, we can gain extra insights into patient outcomes, how well treatments work, and patients' experiences beyond traditional clinical trials. Future studies should concentrate on improving data quality, ensuring different systems can work together, validating the information, and creating standardized ways to combine digital data with RWE. Having proper rules and methods will be crucial for the trustworthy use of real-world information obtained through digital means. 

8.5 Patient-Centred Digital Clinical Research

Digital health technologies are set to help make clinical research more focused on patients. Tools like mobile apps, telemedicine, electronic patient-reported outcomes (ePROs), wearables, and remote monitoring allow trials to take place from home or nearby, making it easier for participants. These methods can lower the need for travel and make it simpler to join studies while also offering more flexibility. In the future, it’s important to prioritize designs that are easy to use, ensure everyone can access them, improve digital skills, provide support for participants, and maintain privacy, safety, and data quality.

8.6 Standardization and Regulatory Development

To use Digital Health Technologies (DHTs) more widely, we need to standardize digital measures, data formats, and validation methods. Having consistent approaches can make the data from different technologies more reliable and easier to compare.

It's also crucial to have clear rules for digital biomarkers, digital endpoints, and real-world data created by DHTs. Working together with researchers, tech developers, healthcare workers, and regulatory agencies can help us implement these technologies responsibly while ensuring good data quality, safety, privacy, and ethical standards.

8.7 Integration of Emerging Technologies

Future clinical studies might increasingly use AI/ML, wearable devices, mobile technology, remote monitoring, and digital markers together. By combining different digital health tools (DHTs), researchers can get a better understanding of both patient data and clinical information.Connected digital systems can improve our ability to collect data, monitor progress, and assess outcomes. They can also support hybrid and decentralized clinical trials.. For this integration to work well, we will need to focus on making sure the systems can communicate with each other, ensuring the quality of the data, validating it, protecting privacy, and following regulations.

8.8 Personalized and Adaptive Clinical Research

New digital technologies can help make clinical research more personalized. Data collected continuously from wearables, mobile apps, and remote monitoring can track individual patterns and changes over time. By combining this digital data with advanced analytics, researchers can better assess how well treatments are working for each person and the outcomes they experience. Using digital technologies in a flexible way allows researchers to adjust certain trial activities based on the needs of the study and the participants, all while ensuring that validation, data quality, privacy, and regulations are properly managed.[12,19]

CONCLUSION

Digital health technologies play a key role in today’s clinical research, helping to move away from traditional site-based trials towards hybrid and decentralized models. Tools like telemedicine, mobile apps, wearables, electronic patient-reported outcomes (ePROs), remote monitoring, and eConsent allow patients to participate from afar, gather digital data, and create trial processes that focus on the patient. These technologies can make it easier for participants by improving recruitment and retention, increasing data availability, collecting real-world data, and enhancing the overall efficiency of trials. However, using these tools requires careful consideration of privacy issues, cybersecurity measures, data quality, validation processes, interoperability, accessibility, technical infrastructure needs, regulatory requirements, and participant commitment.

In the future, clinical research is likely to see more use of artificial intelligence/machine learning (AI/ML), advanced wearables, digital biomarkers, real-world evidence, and decentralized methods. For these technologies to be effectively used, it will be important to have standardization, validation processes, and suitable regulatory frameworks in place.

REFERENCES

1. Rogers A, De Paoli G, Subbarayan S, et al. A systematic review of methods used to conduct decentralised clinical trials. British Journal of Clinical Pharmacology. 2022;88(6):2843–2862.
2. Koller C, Blanchard M, Hügle T. Assessment of digital therapeutics in decentralized clinical trials: A scoping review. PLOS Digital Health. 2025;4(6):e0000905.
3. Sathianathen E, et al. Data-driven and technology-enabled trial innovations toward decentralization of clinical trials: Opportunities and considerations. Journal of Clinical and Translational Science. 2023;7(1):e122.
4. Pyper E, McKeown S, Hartmann-Boyce J, Powell J. Digital health technology for real-world clinical outcome measurement using patient-generated data: Systematic scoping review. Journal of Medical Internet Research. 2023;25:e46992.
5. Rosa C, Campbell AN, Mennenga S, French S, Kervinen J. Using digital technologies in clinical trials: Current and future applications. Contemporary Clinical Trials. 2015;45(Pt A):41–54.
6. Gryak J, et al. Collection and analysis of adherence information for software as a medical device clinical trials: Systematic review. JMIR mHealth and uHealth. 2023;11:e44659.
7. Huh KY, et al. Evaluation of digital therapeutics. Clinical Pharmacology & Therapeutics. 2022;112(3):498–506.
8. Mao Y, et al. Digital health technologies in clinical trials for rare diseases: Current landscape and future directions. Orphanet Journal of Rare Diseases. 2023.
9. van Boven JFM, et al. Digital technologies in clinical trials for asthma: Opportunities and challenges. 2025.
10. Izmailova E, et al. Digital health technology derived measures: Biomarkers or clinical outcome assessments? 2023.
11. Ortega Durán E, et al. Implementation of digital health technology in clinical trials: The 6R framework. 2023.
12. Mahadik B, et al. Harnessing digital health technologies and real-world evidence to enhance clinical research and patient outcomes. 2025.
13. Cummins MR, et al. Decentralized research technology use in multicenter clinical research studies based at U.S. academic research centers. JAMIA Open. 2023.
14. Sato T, et al. Implementation status and consideration for the globalization of decentralized clinical trials: A cross-sectional analysis of clinical trial databases. Trials. 2023.
15. Sinha S, et al. Decentralization in clinical trials and patient centricity: Benefits and challenges. 2024.
16. Chen C, et al. Decentralized clinical trials: Opportunities, challenges and regulatory perspectives. 2025.
17. Copland R, et al. The digital platform and its emerging role in decentralized clinical trials. 2024.
18. Yusuf M, et al. Ethical conduct of electronic informed consent in health research: A scoping review. 2022.
19. Mumtaz H, et al. Current challenges and potential solutions to the use of digital health technologies in evidence generation: A narrative review. 2023.
20. Steinbeck V, Langenberger B, Schöner L, et al. Electronic Patient-Reported Outcome Monitoring to Improve Quality of Life After Joint Replacement: Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open. 2023;6(9):e2331301. doi:10.1001/jamanetworkopen.2023.31301.